Diabetologie und Stoffwechsel 2021; 16(04): 324
DOI: 10.1055/s-0041-1730862
Late-Breaking-Abstract

Loss of Hsp70 leads to increased albuminuria in a STZ-induced diabetic mouse model

J Zemva
1   Universitätsklinikum Heidelberg, Innere Medizin I und klinische Chemie, Heidelberg, Germany
,
R Bulkescher
1   Universitätsklinikum Heidelberg, Innere Medizin I und klinische Chemie, Heidelberg, Germany
,
T Poth
2   Universitätsklinikum Heidelberg, Institut für Pathologie, Heidelberg, Germany
,
I Hausser
2   Universitätsklinikum Heidelberg, Institut für Pathologie, Heidelberg, Germany
,
C Rodemer
1   Universitätsklinikum Heidelberg, Innere Medizin I und klinische Chemie, Heidelberg, Germany
,
A Erhardt
1   Universitätsklinikum Heidelberg, Innere Medizin I und klinische Chemie, Heidelberg, Germany
,
J Okun
3   Universitätsklinikum Heidelberg, Dietmar-Hopp-Stoffwechselzentrum, Heidelberg, Germany
,
S Herzig
4   Helmholtz Zentrum München, Helmholtz Diabetes Center, München-Neuherberg, Germany
,
J Szendrödi
1   Universitätsklinikum Heidelberg, Innere Medizin I und klinische Chemie, Heidelberg, Germany
,
P Nawroth
1   Universitätsklinikum Heidelberg, Innere Medizin I und klinische Chemie, Heidelberg, Germany
› Author Affiliations
 
 

    Background The stress-inducible heat shock protein 70 (Hspa1a/Hspa1b) is involved in refolding of misfolded proteins as well as disaggregation of protein aggregates. Posttranslational modifications, for example by glycation during hyperglycemia, can lead to misfolding, aggregation and loss-of-function of the protein.The aim of this study was to investigate the loss of Hspa1a/Hspa1b in a STZ-induced diabetic mouse model in terms of the development of diabetic nephropathy. Methods: Diabetes was induced at the age of 10 weeks; mice were sacrificed at the age of 28 weeks. Urine was collected for 24hrs just before organ collection; albumine and creatinine were measured via ELISA. Protein expression was analyzed via Western Blot and Immunohistochemistry. Morphologic changes of diabetic nephropathy were assessed by Immunohistochemistry and electron microscopy. Results: Hspa1a/Hspa1b knockout mice (KO) did not differ from wild-type mice (WT) in the control or STZ-treated group in respect to bodyweight or blood glucose levels. STZ-treated KO mice (KO+STZ) revealed to have a significantly higher albumine/creatinine ratio (ACR) compared to STZ-treated wild-type mice (WT+STZ) and to controls (KO-STZ). KO+STZ and WT+STZ showed atrophic proximal tubuli in the outer layers of the kidney parenchyma with thickening of the basal membrane. Furthermore, WT+STZ mice showed decreased Hspa1a/Hsapa1b protein expression compared to WT-STZ mice. Conclusion: Loss of Hspa1a/Hspa1b resulted in elevated ACR in a STZ-induced diabetic mouse model. KO+STZ and WT+STZ mice, showed atrophic proximal tubuli. Furthermore, Hspa1a/Hspa1b seemed downregulated in WT+STZ mice. This supports preliminary human data, where Hspa1a/Hspa1b expression is lost in the course of diabetic nephropathy.


    #

    Interessenskonflikt

    This project is funded by the German Research Foundation (DFG, SFB1118)

    Publication History

    Article published online:
    19 August 2021

    © 2021. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany